Mutual Fund Ownership
Ownership as on: Sat, 20 Apr, 2024

LIC MF Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)3.57
% of AUM5.78%

LIC MF Flexi Cap Fund Growth

2/5
Equity
Amount Invested (Cr.)31.48
% of AUM3.34%

HDFC Pharma and Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)23.51
% of AUM2.94%

LIC MF Long Term Value Fund Growth

2/5
Equity
Amount Invested (Cr.)2.41
% of AUM2.25%

Franklin India Opportunities Fund Growth

NA
Equity
Amount Invested (Cr.)64.11
% of AUM2.17%

FAQs about Piramal Pharma share price

Piramal Pharma is trading at 139.35 as on Fri Apr 19 2024 09:59:48. This is -1.76% lower as compared to its previous closing price of 141.85.

The market capitalization of Piramal Pharma is 18365.64 Cr as on Fri Apr 19 2024 09:59:48.

The average broker rating on Piramal Pharma is Strong Buy. The breakup of analyst rating is given below -

  • 4 analysts have given a strong buy rating
  • 0 analysts have given a buy rating
  • 0 analysts have given a hold rating
  • 0 analysts have given a sell rating
  • 0 analysts have given a strong sell rating

The 52 wk high for Piramal Pharma is 149.00 whereas the 52 wk low is 67.88

Piramal Pharma can be analyzed on the following key metrics -

  • TTM P/E: -
  • Sector P/E: 30.14
  • Dividend Yield: 0.00%
  • D/E ratio: -

Piramal Pharma reported a net profit of -186.46 Cr in 2023.

Recommended For You
Trending Stocks
7,107.00+217.75(3.16%)
2,082.90+58.75(2.90%)
1,531.30+36.70(2.46%)
1,450.00-17.65 (-1.20%)
2,437.10-25.65 (-1.04%)
HomeMarketsPremiumFor youGet App